● Creso Pharma and Red Light Holland have entered into a definitive agreement to merge their businesses and create The HighBrid Lab ● The HighBrid Lab is expected to have an implied pro forma equity value of C$347 million (A$371 million) based on the closing price of the shares of Creso Pharma and Red Light Holland on June 15 th, 2021 ● Transaction results in a reverse takeover of Red Light…


Previous articleBright Minds Biosciences Announces Application to List on Nasdaq
Next articlePsilocybin for Depression: A Q&A between Robin Carhart-Harris & a Psilocybin Study Participant